|
1
|
Brikenfeld B and Listewnik M: Nuclear
Medicine, molecular imaging. Wyd. PUM. 2011.(In Polish).
|
|
2
|
Kordek R, Jassem J, Jeziorski A, Kornafel
J, Krzakowski M and Pawlęga J: Oncology, textbook for students and
doctors. Via Medica, Gdańsk. 2007.(In Polish).
|
|
3
|
Windorbska W, Partyka A, Lewandowska A and
Małkowski B: Assessment of diagnostic value of FDG-PET / CT in
diagnosis of melanoma patients. Onkologia. 11:42007.(In
Polish).
|
|
4
|
Vancauwenberghe T, Snoeckx A,
Vanbeckevoort D, Dymarkowski S and Vanhoenacker FM: Imaging of the
spleen: What the clinician needs to know. Singapore Med J.
56:133–144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Balch CM, Gershenwald JE, Soong SJ,
Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG,
Ding S, et al: Final version of 2009 AJCC melanoma staging and
classification. J Clin Oncol. 27:6199–6206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anna N: Pashali; the role of nuclear
medicine in malignant melanoma. J Nucl Med. 6:42015.
|
|
7
|
Powell P, Charles M and Rathan M:
Subramaniam 18F-fdg pet/ct and melanoma: Staging, immune modulation
and mutation-targeted therapy assessment and prognosis. AJR Am J
Roentgenol. 205:259–270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Steinert HC: PET and PET/CT of malignant
melanomaSkin cancer: A world-wide perspective. Dummer R, Pittelkow
MR, Iwatsuki K, Green A and Elwan MN: Springer; Berlin, Germany:
pp. 379–390. 2011
|
|
9
|
Nanni C, Fantini L, Nicolini S and Fanti
S: Non FDG PET. Clin Radiol. 65:536–548. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Crippa F, Leutner M, Belli F, Gallino F,
Greco M, Pilotti S, Cascinelli N and Bombardieri E: Which kinds of
lymph node metastases can FDG PET detect? A clinical study in
melanoma. J Nucl Med. 41:1491–1494. 2000.PubMed/NCBI
|
|
11
|
Xing Y, Bronstein Y, Ross MI, Askew RL,
Lee JE, Gershenwald JE, Royal R and Cormier JN: Contemporary
diagnostic imaging modalities for the staging and surveillance of
melanoma patients: A meta-analysis. J Natl Cancer Inst.
103:129–142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Krug B, Crott R, Lonneux M, Baurain JF,
Pirson AS and Vander Borght T: Role of PET in the initial staging
of cutaneous malignant melanoma: Systematic review. Radiology.
249:836–844. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schröer-Günther MA, Wolff RF, Westwood ME,
Scheibler FJ, Schürmann C, Baumert BG, Sauerland S and Kleijnen J:
F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and
PET/computed tomography imaging in primary staging of patients with
malignant melanoma: A systematic review. Syst Rev. 1:622012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cobelschi C, Maier A, Hogea MD, Gheorghiu
AR and Toader I: SplenicTuberculosis-case report. Chirurgia
(Bucur). 111:165–169. 2016.PubMed/NCBI
|
|
15
|
Dede F, Doğan E, Demir M, Sener D, Kös M,
Tad M and Eskioğlu E: Unusual presentation of tuberculosis as a
splenic mass. Tohoku J Exp Med. 210:79–82. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Joshi S, Bankar M, Kagal A, Rane S,
Bharadwaj R and Phadke M: Splenic tuberculosis-a rare case report.
Int J Med Update. 2:38–41. 2007.
|
|
17
|
Gupta PP, Fotedar S, Agarwal D and
Sansanwal P: Tuberculosis of spleen presenting with pyrexia of
unknown origin in a non-immunocompromised woman. Lung India.
25:22–24. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh TB, Niyas J, Subhalaxim L, Singh KR,
Singh SK and Singh THB: Splenic tuberculosis-a rare case report.
JMSCR. 3:8454–8457. 2015.
|
